Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action

https://doi.org/10.1016/j.jep.2004.03.052Get rights and content

Abstract

Antitumor and immunomodulatory activities of an aqueous extract (GF100) of Acanthopanax senticosus were examined. In experimental lung metastasis of colon26-M3.1 carcinoma cells, intravenous (i.v.) administration of GF100 2 days before tumor inoculation significantly inhibited lung metastasis in a dose-dependant manner. The i.v. administration of GF100 also exhibited the therapeutic effect on tumor metastasis of colon26-M3.1 cells, when it was injected 1 day after tumor inoculation. In an in vitro cytotoxicity analysis, GF100 at the concentration up to 1000 μg/ml did not affect the growth of colon26-M3.1 cells. In contrast, GF100 enhanced the responsiveness to a mitogen, concanavalin A (ConA), of splenocytes in a dose-dependent manner. Peritoneal macrophage stimulated with GF100 produced various cytokines such as IL-1β, TNF-α, IL-12 and IFN-γ in an in vitro experiment. The macrophages obtained from the mice which were injected with GF100 (500 μg) 3 days before the assay showed significantly higher tumoricidal activity against tumor cells than that of the untreated macrophages. In addition, the i.v. administration of GF100 significantly augmented NK cytotoxicity to Yac-1 cells. The depletion of NK cells by injection of rabbit anti-asialo GM1 serum completely abolished the inhibitory effect of GF100 on lung metastasis of colon26-M3.1 cells. These data suggest that GF100 has antitumor activity to inhibit tumor metastasis prophylactically as well as therapeutically, and its antitumor effect is associated with activation of macrophages and NK cells.

Introduction

Acanthopanax senticosus, also called the “Siberian Ginseng” or “Eleutherococcus senticosus”, has been well known to be prophylactic for various diseases such as chronic bronchitis, hypertension and ischemia (Yi et al., 2001). Acanthopanax senticosus is also known to be effective for reducing many kinds of stress (Gaffney et al., 2001) or fatigue (Dowling et al., 1996). Today this oriental herb is called ‘adatogen’ in the US (Davydov and Krikorian, 2000). Recently, Davydov and Krikorian (2000) reported that the herb included various compounds such as acanthosides, eleutherosides, senticoside, triterpenic saponin, flavon, vitamins and minerals, and they are related to its diverse biological activities. Interestingly, many investigators demonstrated two contrary views on the immunomodulatory effect of Acanthopanax senticosus: the stimulation (Schmeda-Hirschmann et al., 2001, Schmolz et al., 2001) and the suppression (Jeong et al., 2001, Yi et al., 2001, Umeyama et al., 1992) of immune responses. In fact, the stem of the herb has been clinically used for treatment of allergy in Korea. However, the precise mechanisms related to its immunomodulatory activities are still unclear.

It is well known that most death caused by cancer are not due to primary tumor but the dissemination of tumor cells to secondary sites by a series events known to collectively as the metastatic cascade (Fidler, 1991, Liotta et al., 1991). Many experimental studies and clinical trials showed that natural immunity played an important role in blocking of metastasis from primary tumors (Schantz et al., 1987). Among various immune-related cells, NK cells and macrophages were thought to be the relevant effectors responsible for the natural immunity against tumors (Barlozzari et al., 1985, Andreesen et al., 1990). Thus, it is possible that the functional activation of NK cells and macrophages elicit the suppression of tumor growth as well as the inhibition of tumor metastasis. Indeed, it was reported that activation of NK cells and macrophages by plant extracts could control the growth of tumor cells and their metastasis (Yoon et al., 1998, Saiki, 2000).

In this study, we investigated the anti-tumor activity of the aqueous extract (GF100) of Acanthopanax senticosus in respect to the prophylactic and therapeutic inhibition of lung metastasis of colon26-M3.1 carcinoma cells using experimental metastasis model in syngeneic mice, and analyzed the involvement of activation of NK cells and macrophages in its antimetastatic effect against tumors.

Section snippets

Preparation of Acanthopanax senticosus extract

The barks of Acanthopanax senticosus originated from China were purchased from a herbal medicine company (Daehyo Pharm., Korea). The barks were mixed with 20 volumes of distilled water, homogenized for 1 min and then stirred at 4 °C overnight. After centrifuge at 9000 rpm for 20 min, the supernatant was filtered with 0.2 μm pore sized filters and lyophilized. Finally, 5.5 g of the dried extract was obtained from 100 g of the barks of Acanthopanax senticosus. An appropriate amount of obtained brown

Inhibitory effect of GF100 on experimental lung metastasis

In order to investigate if GF100 has antitumor activity to inhibit tumor metastasis, we examined the prophylactic effect of GF100 on the experimental lung metastasis produced by colon26-M3.1 cells. Table 1 shows that i.v. administration of GF-100 (100–500 μg/mouse) 2 days before tumor inoculation significantly inhibited lung metastasis of colon26-M3.1 cells in a dose-dependent manner. However, the smaller amount of GF100 (20 μg/mouse) had no effect. Similarly, treatment with 100–500 μg/mouse of

Discussion and conclusions

Biological response modifier (BRM) has been thought to be a useful tool to suppress tumor growth and inhibit tumor metastasis (Suto et al., 1994, Yoo et al., 1994). In fact, various BRMs such as natural products involving oriental medicines, cytokines, synthetic adjuvants having biological activity to enhance host defense system have been applied to cancer immunotherapy (Suto et al., 1994, Schmeda-Hirschmann et al., 2001, Kang et al., 2002, Saiki, 2000). In many cases, BRMs activate

References (30)

  • C.N Baxevanis et al.

    Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice

    European Journal of Immunology

    (2000)
  • T Deyama et al.

    Constituents and pharmacological effects of Eucommia and Siberian ginseng

    Acta Pharmacologica Sinica

    (2001)
  • E.A Dowling et al.

    Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance

    Medicine and Science in Sports and Exercise

    (1996)
  • M Dubois et al.

    Colorimetric method for determination of sugars and related substances

    Analytical Chemistry

    (1956)
  • I.J Fidler

    Cancer metastasis

    British Medical Bulletin

    (1991)
  • Cited by (71)

    • Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines

      2018, Journal of Ethnopharmacology
      Citation Excerpt :

      Many studies have indicated that Aidi or its active ingredients, such as cantharidin, ginsenosides, astragalosides, and terpenoid compounds, polysaccharides extracted from acanthopanax senticosus, etc. have the anti-tumor and immunomodulatory effects in lung cancer. ( Cichello et al., 2015; Ge et al., 2017; Hsieh et al., 2017; Hsia et al., 2016; Huang et al., 2011; Meng, et al., 2018. Xiao, et al., 2016; Zhang et al., 2014) Ginseng increases the mitochondrial accumulation of apoptosis protein and downregulate the expression of anti-apoptotic protein; the extract of acanthopanax senticosus has antitumor activity to inhibit tumor metastasis, and its antitumor effect is associated with activation of macrophages and NK cells; cantharidin impairs cell migration and Invasion of lung cancer cells; ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin, attenuates cisplatin resistance in lung cancer, and resume immune; astragaloside IV sensitizes non-small cell lung cancer cells to gefitinib,etc. (Dai et al., 2017; Hsia et al., 2016; Jiang et al., 2017; Majeed et al., 2018; Wang et al., 2018; Yoon et al., 2004) According to Response Evaluation Criteria in Solid Tumors (RECIST), assessment of the change in tumor burden is an important feature of the clinical evaluation of cancer therapeutics: both tumor shrinkage (objective response) and disease progression are useful endpoints in clinical trials. (

    • Antimetastatic effect of glycoprotein isolated from rice bran on colon 26-M3.1 cell line

      2017, Journal of Functional Foods
      Citation Excerpt :

      Interestingly, glycoproteins extracted from other plants origins such as Antrodia cinnamomea (Fa et al., 2015) and Acanthopanax senticosus (Ha et al., 2004) have been reported to inhibit metastasis. Our previous studies reported that inhibition of lung metastasis by colon 26-M3.1 cells involved with innate immune responses including NK cell and macrophage activation (Ha et al., 2004; Yoon et al., 2004, 2008). NK cells are prototype innate lymphoid cells that are endowed with potent cytolytic functions that provide host defense mechanisms against microbial infection and tumors (Morvan & Lanier, 2016).

    View all citing articles on Scopus
    1

    The authors equally contributed as corresponding authors to this study.

    View full text